Maynard Um
-
-
-
-
-
-
-
ANI Pharma (ANIP) Tops Q4 EPS by 36c ; Offers Guidance
-
-
-
-
-
-
-
ANI Pharmaceuticals (ANIP) PT Raised to $77 at Truist Securities
-
-
-
-
-
-
-
Truist Lays Out Prelim Thoughts on Impact to Generic Drugs Amid WH Update on Drug Pricing
-
-
-
-
-
-
-
Jefferies Starts ANI Pharmaceuticals (ANIP) at Buy
-
-
-
-
-
-
-
ANI Pharma (ANIP) Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on ANI Pharmaceuticals (ANIP)
-
-
-
-
-
-
-
ANI Pharma (ANIP) Announces Proposed Convertible Senior Notes Offering
-
418,471 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

